82 stories found
Shares of Tilray continue to lose ground as investor enthusiasm fades over the delayed federal rescheduling of marijuana, raising questions about the company's near-term trajectory if political progress stalls.
Questerre Energy shares saw an increase today, while other small-cap companies like Tilray, Aurora, and Canaccord also provided updates to the market.
Tilray has announced its decision to discontinue brewing activities at its Terrapin site located in the United States. This move signifies a change in the company's operational strategy within the US market.
According to Jefferies, Tilray Brands is positioned to create long-term value through its diversified platform.
Earnings previews have been announced for Tilray and Enphase Energy, with investors anticipating their Q2 financial results. Expectations are being set for what these companies will report.
The Chief Executive Officer of BrewDog has resigned from the company in the wake of its acquisition by Tilray, a cannabis and consumer packaged goods company.
Cannabis company Tilray is experiencing significant international growth, with a 73% increase, yet the market appears to be largely ignoring this development, prompting questions about its valuation.
Tilray Brands Inc. (TLRY) is presented as a potential top 'sin stock' investment, with the article exploring the reasons behind this assessment.
An article explores whether Tilray represents the best value investment opportunity within the rapidly growing $7.4 billion cannabis beverage market.
Tilray's recent performance illustrates how quickly a policy-driven trade can lose momentum in the market.
A Wall Street analyst has issued a bullish forecast, suggesting that Tilray stock could see a jump of over 40% in value.
Tilray Brands (TLRY) is reportedly experiencing continued strength driven by its international business operations.
This article examines the factors that led to Tilray stock experiencing a significant decline in the market during March.
Tilray's Shock Top brand has introduced its most potent beer to date, expanding its product line in the competitive beverage market.
Tilray Brands, Inc. released its Q3 2026 earnings summary, detailing the company's financial performance for the period.
Tilray has reported its FQ3 earnings, beating revenue estimates but missing on profit, while reaffirming its financial outlook for fiscal year 2026.
Several major companies, including Nike, Tilray, Virgin Galactic, Beyond Meat, Nano Dimension, and Conagra Brands, are scheduled to release their earnings reports in the coming week.
Tilray Brands announced a significant expansion of its medical cannabis product portfolio in Australia, strengthening its presence in the market.
Tilray Brands has agreed to acquire key assets of BrewDog across North America, expanding its portfolio and presence in the American market, following a previous UK rescue deal.
Tilray Brands has expanded its global footprint by completing the acquisition of BrewDog Brewing Australia's assets, further solidifying its presence in the Australian market.
Tilray Brands (TLRY) is showing strong performance, driven by its diversification into beverages and the launch of new spring products.
Hundreds of Brewdog staff were laid off during a 15-minute call following the independent brewer and pub chain's £33 million acquisition by US beverage and cannabis firm Tilray.
Tilray Brands, which produces medicinal cannabis and craft beer in the US, bought the BrewDog brand in a £33 million deal.
An article advises caution regarding Tilray stock, suggesting investors read a warning before making purchasing decisions.
Tilray Brands has announced a partnership with Carlsberg to handle brewing operations in the United States.
Alliance Global has maintained a neutral rating on Canopy Growth Corporation (CGC), while Canaccord has expressed a bullish outlook on Aurora Cannabis Inc. (ACB).
Investment guide compares the two leading cannabis equities to determine which offers better near-term growth potential for retail investors.
Tilray, Canopy Growth, and Aurora Cannabis stocks saw gains of 6%, 3%, and 4% respectively, even as Tilray remains down 47% year-to-date, highlighting volatility in the cannabis sector.
Tilray Brands has posted record numbers for fiscal year 2026, but despite the strong performance, analysts suggest that these results are not sufficient to make the stock a recommended buy.
Several companies, including Tilray, Clearwater Paper, XPLR, and Innio, have released their adjusted EBITDA projections for fiscal years ranging from 2026 to 2027. These forecasts highlight anticipated financial performance driven by factors such as margin expansion, price increases, and capacity growth.
Investors are evaluating whether to purchase Tilray Brands stock ahead of July 28, considering various market factors and potential catalysts.
Investors are evaluating whether to purchase Tilray stock before July 15, indicating a key decision point for the cannabis company's shares.
Cannabis company Tilray has announced the acquisition of HelloMD, a digital health platform.
An analysis compares Tilray and Trulieve to determine which marijuana stock presents a better buying opportunity for investors.
Tilray Brands Inc (TLRY) is participating in European discussions concerning cannabis regulations.
Despite speculation, Tilray Brands is not expected to expand into the U.S. marijuana market anytime soon, according to a recent analysis.
Amid escalating tensions with Iran, European nations and the UK are discussing plans to secure the Strait of Hormuz. The US has increased its naval presence in the region and issued warnings to Iran, with reports of a US naval blockade advancing into international waters.
Tilray stock experienced a rally, reportedly driven by new hopes related to cannabis policy under the Trump administration.
Genius Group has priced an $8 million securities offering, while Tilray has announced a $180 million equity offering alongside debt-for-equity deals to issue 1.9 million shares. Both companies are raising capital through these financial transactions.
Investors in Tilray Brands should not anticipate the company to post a profit anytime soon, according to recent analysis.
Jefferies analysts maintain a bullish outlook on Tilray Brands, citing the company's strong cannabis sales and an upbeat future outlook.
NovaGold Resources announced a GAAP EPS of -$0.04, missing analyst estimates by $0.01, indicating a slight underperformance in its financial results.
Investors and analysts are anticipating the Q3 earnings report from cannabis company Tilray, with expectations for its financial performance.
Brewdog faces accusations of employing a 'fire and rehire' strategy towards former workers after its brewery and 11 bars were acquired by US firm Tilray for £33 million following administration.
An investor expresses a strong negative sentiment towards Tilray Brands stock, advising against investment.
Lord's cricket ground has terminated its partnership with BrewDog following the acquisition of the beer company by Tilray Brands, which produces medicinal marijuana.
Tilray Brands, Inc. (TLRY) is strengthening its U.S. market presence through a new long-term partnership with Carlsberg.
Beverage and cannabis company Tilray has acquired Brewdog for £33 million after the brewery went into administration, resulting in bar closures and hundreds of job losses.
Beverage and cannabis company Tilray acquires the Aberdeenshire brewery, the brand and 11 bars for £33m.
An analysis compares Canopy Growth and Tilray Brands to determine which stock has greater potential to generate significant wealth for investors.
Tilray Brands and Carlsberg Group have established an exclusive multi-year brewing partnership in the United States.
Tilray announced record revenue for fiscal year 2026, prompting questions about why its stock price has not seen a corresponding rally.
Tilray Brands is projecting to achieve a significant milestone of $1 billion in annual revenue for the current fiscal year, outlining its strategic plans to reach this target.
Tilray Brands saw an 8% increase in its stock price, extending gains from the previous day.
Tilray's stock rose despite the company missing its fourth-quarter bottom line, buoyed by strong guidance for FY27 EBITDA growth.
Tilray's stock has seen a significant decline of over 50% this year, prompting analysis into whether it now represents a bargain buying opportunity.
Tilray Brands (TLRY) has completed the acquisition of HelloMD Corporation, a move that is expected to bring strategic gains to the cannabis company.
An article provides an analysis on whether the current market conditions present a favorable opportunity to buy shares of Tilray Brands, a prominent cannabis company.
This story analyzes the market factors that could significantly impact Tilray stock, while also noting Palo Alto Networks' recent stock performance, which saw a 57.1% surge last month before a June decline. It highlights the volatility and key influences on these companies' shares.
Five years after the merger of Tilray and Aphria to form a 'global cannabis leader,' an article reviews the combined company's performance and trajectory.
The CEO of Tilray (TLRY) has commented on the potential reclassification of cannabis in the United States, a topic of significant interest in the industry.
The US Navy Secretary was ousted from his position effective immediately, following reports of internal conflicts and disagreements with senior Pentagon officials.
An article delves into the factors behind Tilray Brands' disappointing investment returns, despite its operations within the legal marijuana market.
Tilray announced record financial results for the last quarter, with the bulk of its growth over the past four years coming from unexpected sources.
An investment perspective suggests that stable dividend-paying stocks offer a more prudent strategy compared to speculative options like Tilray.
Tilray's stock experienced a rebound after Roth Capital upgraded its rating to "Buy," following the release of the company's third-quarter financial results.
Tilray Brands announced its third-quarter financial results, showing double-digit year-over-year increases in most segmental revenues, though its alcohol segment experienced a 24% slump.
The heirs of music icon Bob Marley have launched an $11 million lawsuit against cannabis company Tilray, alleging unpaid licensing fees for the Marley Natural brand.
The CEO of Tilray Brands has commented on the future of BrewDog, emphasizing the need for stability within the company.
An analysis questions whether Tilray Brands' diversification strategy will ultimately benefit investors, examining the potential outcomes of its business decisions.
Tilray Brands has announced expectations to generate $1.2 billion in revenue in the upcoming year, with the company's strategy potentially surprising investors.
Cannabis company Tilray has acquired the craft beer brand Brewdog, a move that has left its small investors, known as 'Equity Punks,' feeling betrayed. The acquisition follows a period of decline for Brewdog, which was once celebrated for its marketing stunts.
The independent brewer and pub chain has been bought by US beverage and cannabis firm Tilray in a £33m deal.
US beverage and cannabis company Tilray has acquired Brewdog, its brand, and 11 bars for £33 million after the brewery went into administration, resulting in bar closures and hundreds of job losses.
Tilray Brands is reportedly close to finalizing a deal to acquire assets from BrewDog, a craft beer company.
An article raises questions about whether investors should consider selling their shares in Tilray, a cannabis and consumer packaged goods company.
Craft brewer Tilray Brands has announced a new licensing agreement with Carlsberg Group to brew, market, and distribute Carlsberg and other associated brands in the United States.
Irwin Simon, CEO of cannabis and beverage company Tilray, shares insights into his morning routine and his preference for honest feedback over 'yes' people.